Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL882497 | 0.82 | CA12 (0.35) | CA12CA14CA2CA1CA7 | |
| SCHEMBL20087385 | 0.79 | TDP1 (0.40) | CA12CA14CA2CA1CA7 | |
| SCHEMBL22345238 | 0.78 | TSHR (0.41) | CA12CA14CA2CA1CA7 | |
| SCHEMBL1843089 | 0.76 | CA12 (0.47) | CA12CA14CA2CA1CA7 | |
| SCHEMBL3451980 | 0.75 | CA12 (0.38) | CA12CA14CA2CA1CA7 | |
| SCHEMBL11226349 | 0.74 | GAA (0.43) | CA12CA2CA1 | |
| SCHEMBL10724862 | 0.73 | CA12 (0.39) | CA12CA14CA2CA1CA7 | |
| SCHEMBL18776030 | 0.73 | CA12 (0.39) | CA12CA14CA2CA1CA7 | |
| SCHEMBL882495 | 0.72 | THRB (0.40) | — | |
| SCHEMBL14483954 | 0.71 | CA2 (0.38) | CA12CA14CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210285955-A1 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | WARP DRIVE BIO, INC. | 2021-09-16 | — | — | US | disclosed |
| US-20200199102-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Revolution Medicines, Inc. | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210285955-A1 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | FKBP8, PIN1, FKBP1A | CA12 1472/4885CA14 876/4885CA2 1281/4885 |
| US-20200199102-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | PIN1, FKBP14, FKBP2 | CA12 3298/4885CA14 2936/4885CA2 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.